Walgreens Boots Alliance (WBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
05-2024 | 02-2024 | 11-2023 | 08-2023 | 05-2023 | |
Cash Flows From Operating Activities | |||||
Net Income | -12,370,000 | -12,600,000 | -278,000 | -3,528,000 | -3,320,000 |
Depreciation Amortization | 1,837,000 | 1,230,000 | 616,000 | 2,257,000 | 1,652,000 |
Income taxes - deferred | -1,242,000 | -1,331,000 | -196,000 | -2,371,000 | -2,098,000 |
Accounts receivable | -592,000 | -850,000 | -618,000 | 72,000 | -411,000 |
Accounts payable and accrued liabilities | 446,000 | 142,000 | 966,000 | 1,243,000 | 627,000 |
Other Working Capital | -1,588,000 | -1,520,000 | -694,000 | 7,444,000 | 6,642,000 |
Other Operating Activity | 13,195,000 | 14,011,000 | -77,000 | -2,859,000 | -1,873,000 |
Operating Cash Flow | $-314,000 | $-918,000 | $-281,000 | $2,258,000 | $1,219,000 |
Cash Flows From Investing Activities | |||||
PPE Investments | -362,000 | -131,000 | -79,000 | -350,000 | -84,000 |
Net Acquisitions | -206,000 | -228,000 | -109,000 | -7,313,000 | -7,072,000 |
Other Investing Activity | 1,674,000 | 1,261,000 | 273,000 | 4,569,000 | 3,907,000 |
Investing Cash Flow | $1,106,000 | $902,000 | $85,000 | $-3,094,000 | $-3,249,000 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | -1,000 | 426,000 | 155,000 | -1,000 | 147,000 |
Debt Issued | 23,074,000 | 15,001,000 | 3,826,000 | 6,276,000 | 5,240,000 |
Debt Repayment | -23,128,000 | -14,948,000 | -3,776,000 | -8,978,000 | -5,232,000 |
Common Stock Issued | N/A | N/A | N/A | 45,000 | N/A |
Common Stock Repurchased | -69,000 | -69,000 | -69,000 | -150,000 | -150,000 |
Dividend Paid | -1,044,000 | -828,000 | -415,000 | -1,659,000 | -1,244,000 |
Other Financing Activity | 256,000 | 291,000 | 465,000 | 3,580,000 | 1,812,000 |
Financing Cash Flow | $-912,000 | $-127,000 | $186,000 | $-887,000 | $573,000 |
Exchange Rate Effect | 3,000 | 2,000 | N/A | 20,000 | 17,000 |
Beginning Cash Position | 856,000 | 856,000 | 856,000 | 2,558,000 | 2,558,000 |
End Cash Position | 740,000 | 715,000 | 846,000 | 856,000 | 1,117,000 |
Net Cash Flow | $-117,000 | $-142,000 | $-10,000 | $-1,702,000 | $-1,441,000 |
Free Cash Flow | |||||
Operating Cash Flow | -314,000 | -918,000 | -281,000 | 2,258,000 | 1,219,000 |
Capital Expenditure | -1,135,000 | -858,000 | -506,000 | -2,117,000 | -1,633,000 |
Free Cash Flow | -1,449,000 | -1,776,000 | -787,000 | 141,000 | -414,000 |